selenotifen

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug Nameselenotifen
Drug Alias NameSelenium ketotifenBN-52256
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonistsPlatelet activating factor receptor antagonists
TargetsHistamine H1 receptorPlatelet activating factor receptor
Therapy Area/IndicationsHypersensitivityArrhythmias, CardiacAsthma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIpsen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIpsen Inc
Active IndicationsN/A
Inactive IndicationsHypersensitivityArrhythmias, CardiacAsthma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A